Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Lips, EH"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Middeldorp, A, van Puijenbroek, M, Nielsen, M, Corver, WE, Jordanova, ES, ter Haar, N, Tops, CMJ, Vasen, HFA, Lips, EH, van Eijk, R, Hes, FJ, Oosting, J, Wijnen, J, van Wezel, T, Morreau, H
Publikováno v:
Journal of Pathology; Sep2008, Vol. 216 Issue 1, p25-31, 7p
Autor:
Lips, EH, de Graaf, EJ, Tollenaar, RAEM, van Eijk, R, Oosting, J, Szuhai, K, Karsten, T, Nanya, Y, Ogawa, S, van de Velde, CJ, Eilers, PHC, van Wezel, Tom, Morreau, H
Publikováno v:
Journal of Pathology; Jul2007, Vol. 212 Issue 3, p269-277, 9p
Autor:
Lips EH, van Eijk R, de Graaf EJ, Oosting J, de Miranda NF, Karsten T, van de Velde CJ, Eilers PH, Tollenaar RA, van Wezel T, Morreau H
Publikováno v:
BMC Cancer; 2008, Vol. 8, p314-314, 1p
Autor:
Byng D; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, PA 3062, The Netherlands., Schaapveld M; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands., van Duijnhoven FH; Division of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, ZA 2333, The Netherlands., van Harten WH; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, PA 3062, The Netherlands., Retèl VP; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, PA 3062, The Netherlands.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Dec 16, pp. 1-12. Date of Electronic Publication: 2024 Dec 16.
Autor:
Van Bockstal MR; Department of Pathology, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium. Mieke.VanBockstal@saintluc.uclouvain.be.; Pôle de Morphologie (MORF), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 10, 1200, Brussels, Belgium. Mieke.VanBockstal@saintluc.uclouvain.be., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands., Smidt M; Department of Surgery, Maastricht University Medical Center, P.O. Box 616, 6200 MD, Maastricht, The Netherlands., Galant C; Department of Pathology, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium.; Pôle de Morphologie (MORF), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 10, 1200, Brussels, Belgium., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. c.h.m.vandeurzen@erasmusmc.nl.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Aug 27; Vol. 26 (1), pp. 125. Date of Electronic Publication: 2024 Aug 27.
Autor:
Hutten SJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Messal HA; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sheinman M; Oncode Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ciwinska M; Department of Oncology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium., Braams E; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Borden C; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kristel P; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stoffers S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wessels LF; Oncode Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jonkers J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Scheele CL; Department of Oncology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Jul; Vol. 263 (3), pp. 360-371. Date of Electronic Publication: 2024 May 23.
Autor:
Debets DO; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3584 CH Utrecht, the Netherlands., de Graaf EL; Pepscope B.V, Nieuwe Kanaal 7, 6709 PA Wageningen, the Netherlands., Liefaard MC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ressa A; Pepscope B.V, Nieuwe Kanaal 7, 6709 PA Wageningen, the Netherlands., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3584 CH Utrecht, the Netherlands.
Publikováno v:
IScience [iScience] 2024 Apr 30; Vol. 27 (6), pp. 109858. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
Autor:
Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Voort A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Seijen M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Thijssen B; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vonk S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Bhaskaran R; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Apr 18; Vol. 10 (1), pp. 29. Date of Electronic Publication: 2024 Apr 18.